Partnering for success

Beyond Curve’s pipeline there are multiple applications with clear opportunities for collaborative research and development with partners that have a depth of knowledge in target biology and expertise in drug development.

Curve welcomes the opportunity to collaborate with pharma partners to identify novel hits and leads against their high-priority targets.

Science

Revolutionary Platform

Our Microcycle^® platform allows direct screening for biologically active hits inside mammalian cells and facilitates small molecule hit-to-lead programmes.

Learn More

Pipeline

Challenging cancer targets

We are currently deploying our platform to build a pipeline of first-in-class small molecule drugs to address high priority cancer targets that have evaded conventional discovery approaches.

Learn More